Meadows et al. showed that the level of GDF-15 in the plasma of PAH patients with systemic sclerosis (SSc) is significantly higher than that of SSc patients without pulmonary arterial hypertension (17). This evidence concerns the gene GDF15 and systemic sclerosis.